Group One Trading’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-210,900
| Closed | -$74K | – | 5253 |
|
|
2016
Q3 | $74K | Sell |
210,900
-297,200
| -58% | -$104K | ﹤0.01% | 3121 |
|
|
2016
Q2 | $237K | Buy |
508,100
+486,200
| +2,220% | +$227K | ﹤0.01% | 2284 |
|
|
2016
Q1 | $30K | Sell |
21,900
-847,300
| -97% | -$1.16M | ﹤0.01% | 3543 |
|
|
2015
Q4 | $1.28M | Buy |
869,200
+88,100
| +11% | +$130K | 0.02% | 1141 |
|
|
2015
Q3 | $1.23M | Sell |
781,100
-154,700
| -17% | -$244K | 0.02% | 1095 |
|
|
2015
Q2 | $1.59M | Buy |
935,800
+365,700
| +64% | +$622K | 0.02% | 884 |
|
|
2015
Q1 | $792K | Sell |
570,100
-216,400
| -28% | -$301K | 0.01% | 1261 |
|
|
2014
Q4 | $1.19M | Sell |
786,500
-292,200
| -27% | -$441K | 0.02% | 972 |
|
|
2014
Q3 | $2.22M | Sell |
1,078,700
-952,500
| -47% | -$1.96M | 0.03% | 626 |
|
|
2014
Q2 | $6.21M | Buy |
2,031,200
+265,100
| +15% | +$811K | 0.1% | 226 |
|
|
2014
Q1 | $4.42M | Buy |
1,766,100
+1,161,800
| +192% | +$2.9M | 0.07% | 272 |
|
|
2013
Q4 | $3M | Buy |
604,300
+477,400
| +376% | +$2.37M | 0.05% | 440 |
|
|
2013
Q3 | $288K | Buy |
126,900
+104,800
| +474% | +$238K | 0.01% | 2068 |
|
|
2013
Q2 | $49K | Buy |
+22,100
| New | +$49K | ﹤0.01% | 3454 |
|
Group One Trading's RXII Position: Q4 2016 in Review
Group One Trading sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 135,018 shares — an estimated $47K sold.
Group One Trading first reported a position in RXII in Q1 2014 and held it in 10 quarters. The position peaked at $2M in Q3 2015. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.
- Group One Trading reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
- Group One Trading sold 135,018 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $47K.
- Group One Trading first reported a position in GALENA BIOPHARMA INC COM in Q1 2014 and held it in 10 quarters.
- Group One Trading's GALENA BIOPHARMA INC COM position peaked at $2M in Q3 2015.
- 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.
Based on Group One Trading's 13F filing for Q4 2016, filed 15 Feb 2017.